Newmacoy Soft Capsule (Omega-3 Ethyl Ester 90)

Adult dose

Prior to administration of this medication, an appropriate lipid-lowering dietary regimen must be followed and continued throughout the treatment period. This medication is taken with meals to avoid gastrointestinal disturbances. The usual starting dose is 2g (2 capsules) daily, which can be increased to 4g daily if necessary. It can be administered once or twice a day.

This medication should not be used by individuals who have allergic reactions to any of its components or by children under the age of 18. Caution is advised for individuals with an increased risk of bleeding due to severe trauma or surgery, those with liver function issues, and those allergic to fish. Various side effects such as back pain, cold symptoms, infections, dyspepsia, burping, rash, taste abnormalities may occur during treatment. Rarely, cardiovascular issues, gastrointestinal disturbances, muscle pain, neurological symptoms, and respiratory problems have also been reported. Regular blood tests should be conducted before and during treatment to check triglyceride levels and liver function, and treatment can be discontinued if no effects are seen. Combination with a diet and exercise is important, and precautions should be taken when used with other lipid-lowering medications. Individuals at risk for cardiovascular diseases may experience atrial fibrillation while using this medication, so treatment should be stopped immediately if symptoms arise. Additionally, there may be an increased risk of bleeding when this medication is taken with anticoagulants, therefore regular checks on blood coagulation status are necessary. The safety of this medication during pregnancy or breastfeeding has not been fully established and should be used cautiously only when necessary. Special caution is required for children and the elderly as safety and efficacy have not been sufficiently verified. In case of overdose, there is no specific antidote, and appropriate treatment and supportive therapy should be provided according to symptoms. This medication is known to have a low risk of carcinogenicity, mutagenicity, and reproductive toxicity, but its safety during pregnancy for the fetus has not been established, hence it should be used with caution. This medication should be kept out of reach of children and should not be transferred to other containers as this may affect its quality.

Serious side effects

Atrial fibrillation, angina, cardiac arrest, myocardial infarction, myocardial ischemia, sudden death, asthma, dyspnea, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, severe skin reactions with high fever, generalized edema, hypertension, severe headache, seizures, confusion, visual disturbances, paralysis, jaundice, liver dysfunction (including ALT and AST elevation)

Mild side effects

• Back pain
• cold symptoms
• infection
• pain
• dyspepsia
• burping
• rash
• taste disorder
• abdominal distension
• weakness

This medication should be stored in a sealed container that prevents air from entering, and the temperature should be maintained below 25 degrees Celsius. Also, care should be taken to avoid freezing.

Appearance

Transparent rectangular soft capsule filled with a light yellow oily substance

Package unit

30 capsules/bottle, 60 capsules/bottle, 60 capsules/PTP [(10 capsules/PTPX6)]